# GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma

> **NCT02495454** · PHASE2 · TERMINATED · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 34 (actual)

## Conditions studied

- CD20 Positive Diffuse Large B-cell Lymphoma
- Elderly Unfit Patients

## Interventions

- **DRUG:** Ga101

## Key facts

- **NCT ID:** NCT02495454
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08-25
- **Primary completion:** 2017-03-22
- **Final completion:** 2017-03-22
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Primary objective not obtained after interim analysis
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02495454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02495454, "GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02495454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*